Cargando…

COVID-19 After Lung Resection in Northern Italy

We reviewed surgical cases from 4 Thoracic Surgery departments in the Lombardia region of Italy, the area mostly affected by Coronavirus pandemic in Europe, with the aim to describe the impact of COVID-19 on the treatment of thoracic surgical patients. Clinical, radiological and laboratory data from...

Descripción completa

Detalles Bibliográficos
Autores principales: Scarci, Marco, Raveglia, Federico, Bortolotti, Luigi, Benvenuti, Mauro, Merlo, Luca, Petrella, Lea, Cardillo, Giuseppe, Rocco, Gaetano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111882/
https://www.ncbi.nlm.nih.gov/pubmed/33989754
http://dx.doi.org/10.1053/j.semtcvs.2021.03.038
_version_ 1783690582269362176
author Scarci, Marco
Raveglia, Federico
Bortolotti, Luigi
Benvenuti, Mauro
Merlo, Luca
Petrella, Lea
Cardillo, Giuseppe
Rocco, Gaetano
author_facet Scarci, Marco
Raveglia, Federico
Bortolotti, Luigi
Benvenuti, Mauro
Merlo, Luca
Petrella, Lea
Cardillo, Giuseppe
Rocco, Gaetano
author_sort Scarci, Marco
collection PubMed
description We reviewed surgical cases from 4 Thoracic Surgery departments in the Lombardia region of Italy, the area mostly affected by Coronavirus pandemic in Europe, with the aim to describe the impact of COVID-19 on the treatment of thoracic surgical patients. Clinical, radiological and laboratory data from patients who underwent lung resection from December 2019 to March 2020 were retrospectively collected until June 2020. Univariable Cox regression models were estimated to evaluate potential prognostic factors for developing COVID-19 and to investigate postoperative mortality among patients who developed symptomatic COVID-19 infection. We examined data from 107 patients. (74 lobectomies, 32 wedge/segmentectomies and 1 pneumonectomy). Twelve patients developed COVID-19 (Group 1), whereas 95 patients were not infected (Group 2). In Group 1, 6 patients (50%) died from complications related to infection; in Group 2, one patient (1%) died because of non-COVID-19-related causes. Median days from surgery to first symptoms, CT confirmation, clinical confirmation and PCR positivity was 48.1, 54.3, 55.1, and 55.2 respectively. At univariable analysis, DLCO/VA% (P = 0.008), duration of the surgery (P = 0.009), smoking history (pack/year) (P < 0.001), BMI (P< 0.001) and number of segments resected (P = 0.010) were associated with COVID-19 onset. Moreover, CCI (P < 0.001), DLCO/VA% (P = 0.002), cigarette pack/year (P < 0.001), BMI (P < 0.001) and COVID-19 (P < 0.001) were associated with death. Patients who undergo lung resection and then develop symptomatic COVID-19 infection are at higher risk of developing severe respiratory complications and postoperative death. Insidious symptoms’ onset may lead to a delay in diagnosis. We suggest two mitigating strategies: (1) Improve symptoms surveillance and isolation during recovery period, (2) Be aware of a potential greater risk of developing symptomatic COVID-19 and death correlated with elevated CCI, BMI, smoking history, DLCO/VA%, number of resected segments and duration of surgery.
format Online
Article
Text
id pubmed-8111882
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-81118822021-05-11 COVID-19 After Lung Resection in Northern Italy Scarci, Marco Raveglia, Federico Bortolotti, Luigi Benvenuti, Mauro Merlo, Luca Petrella, Lea Cardillo, Giuseppe Rocco, Gaetano Semin Thorac Cardiovasc Surg THORACIC – Original Submission We reviewed surgical cases from 4 Thoracic Surgery departments in the Lombardia region of Italy, the area mostly affected by Coronavirus pandemic in Europe, with the aim to describe the impact of COVID-19 on the treatment of thoracic surgical patients. Clinical, radiological and laboratory data from patients who underwent lung resection from December 2019 to March 2020 were retrospectively collected until June 2020. Univariable Cox regression models were estimated to evaluate potential prognostic factors for developing COVID-19 and to investigate postoperative mortality among patients who developed symptomatic COVID-19 infection. We examined data from 107 patients. (74 lobectomies, 32 wedge/segmentectomies and 1 pneumonectomy). Twelve patients developed COVID-19 (Group 1), whereas 95 patients were not infected (Group 2). In Group 1, 6 patients (50%) died from complications related to infection; in Group 2, one patient (1%) died because of non-COVID-19-related causes. Median days from surgery to first symptoms, CT confirmation, clinical confirmation and PCR positivity was 48.1, 54.3, 55.1, and 55.2 respectively. At univariable analysis, DLCO/VA% (P = 0.008), duration of the surgery (P = 0.009), smoking history (pack/year) (P < 0.001), BMI (P< 0.001) and number of segments resected (P = 0.010) were associated with COVID-19 onset. Moreover, CCI (P < 0.001), DLCO/VA% (P = 0.002), cigarette pack/year (P < 0.001), BMI (P < 0.001) and COVID-19 (P < 0.001) were associated with death. Patients who undergo lung resection and then develop symptomatic COVID-19 infection are at higher risk of developing severe respiratory complications and postoperative death. Insidious symptoms’ onset may lead to a delay in diagnosis. We suggest two mitigating strategies: (1) Improve symptoms surveillance and isolation during recovery period, (2) Be aware of a potential greater risk of developing symptomatic COVID-19 and death correlated with elevated CCI, BMI, smoking history, DLCO/VA%, number of resected segments and duration of surgery. Elsevier Inc. 2022 2021-05-11 /pmc/articles/PMC8111882/ /pubmed/33989754 http://dx.doi.org/10.1053/j.semtcvs.2021.03.038 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle THORACIC – Original Submission
Scarci, Marco
Raveglia, Federico
Bortolotti, Luigi
Benvenuti, Mauro
Merlo, Luca
Petrella, Lea
Cardillo, Giuseppe
Rocco, Gaetano
COVID-19 After Lung Resection in Northern Italy
title COVID-19 After Lung Resection in Northern Italy
title_full COVID-19 After Lung Resection in Northern Italy
title_fullStr COVID-19 After Lung Resection in Northern Italy
title_full_unstemmed COVID-19 After Lung Resection in Northern Italy
title_short COVID-19 After Lung Resection in Northern Italy
title_sort covid-19 after lung resection in northern italy
topic THORACIC – Original Submission
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111882/
https://www.ncbi.nlm.nih.gov/pubmed/33989754
http://dx.doi.org/10.1053/j.semtcvs.2021.03.038
work_keys_str_mv AT scarcimarco covid19afterlungresectioninnorthernitaly
AT ravegliafederico covid19afterlungresectioninnorthernitaly
AT bortolottiluigi covid19afterlungresectioninnorthernitaly
AT benvenutimauro covid19afterlungresectioninnorthernitaly
AT merloluca covid19afterlungresectioninnorthernitaly
AT petrellalea covid19afterlungresectioninnorthernitaly
AT cardillogiuseppe covid19afterlungresectioninnorthernitaly
AT roccogaetano covid19afterlungresectioninnorthernitaly